Immunome, Inc. (IMNM) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 4.01M | 2.93M | 2.74M | 2.91M | 2.36M | 1.03M | 3.83M | 3.56M | 4.26M |
| Revenue Growth % | -100% | -100% | -100% | 69.84% | 184.35% | -28.44% | -18.37% | -44.55% | -56.47% | - | - | - |
| Cost of Goods Sold | 753K | 0 | 49.19M | 720K | 0 | 0 | 0 | 0 | 0 | 0 | 166K | 5.72M |
| COGS % of Revenue | - | - | - | 17.93% | - | - | - | - | - | - | 4.66% | 134.08% |
| Gross Profit | -753K | 0 | -49.19M | 3.29M | 2.93M | 2.74M | 2.91M | 2.36M | 1.03M | 3.83M | 3.4M | -1.45M |
| Gross Margin % | - | - | - | 82.07% | 100% | 100% | 100% | 100% | 100% | 100% | 95.34% | -34.08% |
| Gross Profit Growth % | -125.73% | -100% | -1790.48% | 39.38% | 184.35% | -28.44% | -14.39% | 262.7% | 166.43% | - | - | - |
| Operating Expenses | 58.58M | 72.86M | 10.95M | 49.77M | 47.56M | 85.71M | 53.43M | 42.37M | 133.33M | 98.48M | 8.03M | 4.32M |
| OpEx % of Revenue | - | - | - | 1239.68% | 1625.5% | 3130.31% | 1836.15% | 1792.43% | 12957.05% | 2573.94% | 225.3% | 101.34% |
| Selling, General & Admin | 12.95M | 12.09M | 10.95M | 10.04M | 10.69M | 10.45M | 9.53M | 6.98M | 6M | 8.04M | 4.38M | 4.32M |
| SG&A % of Revenue | - | - | - | 250.11% | 365.35% | 381.52% | 327.35% | 295.18% | 583.58% | 210.14% | 122.72% | 101.34% |
| Research & Development | 46.38M | 60.77M | 49.19M | 40.45M | 36.87M | 47.89M | 37.2M | 29.08M | 15.37M | 9.64M | 3.82M | 5.72M |
| R&D % of Revenue | - | - | - | 1007.5% | 1260.15% | 1749.09% | 1278.35% | 1230.25% | 1493.59% | 251.88% | 107.24% | 134.08% |
| Other Operating Expenses | -753K | 0 | -1000K | -720K | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | -166K | -1000K |
| Operating Income | -59.33M | -72.86M | -60.14M | -46.48M | -44.64M | -82.97M | -50.52M | -40.01M | -132.3M | -94.65M | -4.63M | -5.77M |
| Operating Margin % | - | - | - | -1157.61% | -1525.5% | -3030.31% | -1736.15% | -1692.43% | -12857.05% | -2473.94% | -129.96% | -135.42% |
| Operating Income Growth % | -32.92% | 12.18% | -19.03% | -16.17% | 66.26% | 12.34% | -990.48% | -593.04% | -2859.05% | -1115.53% | 45.71% | 35.32% |
| EBITDA | -58.58M | -72.08M | -59.55M | -45.76M | -43.91M | -82.38M | -49.95M | -39.34M | -132.04M | -94.4M | -4.47M | -5.67M |
| EBITDA Margin % | - | - | - | -1139.68% | -1500.68% | -3008.58% | -1716.53% | -1663.96% | -12831.49% | -2467.22% | -125.3% | -133.05% |
| EBITDA Growth % | -33.4% | 12.49% | -19.21% | -16.33% | 66.74% | 12.73% | -1018.22% | -593.51% | -2916.59% | -1154.1% | 46.95% | 35.58% |
| D&A (Non-Cash Add-back) | 753K | 776K | 589K | 720K | 726K | 595K | 571K | 673K | 263K | 257K | 166K | 101K |
| EBIT | -59.33M | -72.86M | -57.46M | -46.48M | -44.64M | -55.6M | -43.82M | -33.7M | -20.34M | -13.85M | -4.63M | -5.77M |
| Net Interest Income | 5.49M | 2.96M | 2.68M | 3.08M | 3M | 2.72M | 3.42M | 3.89M | 2.81M | 2.02M | 288K | 216K |
| Interest Income | 5.49M | 2.96M | 2.68M | 3.08M | 3M | 2.72M | 3.42M | 3.89M | 2.81M | 2.02M | 288K | 216K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 5.49M | 2.96M | 2.68M | 3.08M | 3M | 2.72M | 3.42M | 3.89M | 2.81M | 2.02M | 288K | 216K |
| Pretax Income | -53.84M | -69.9M | -57.46M | -43.4M | -41.64M | -80.25M | -47.1M | -36.12M | -129.49M | -92.63M | -4.34M | -5.56M |
| Pretax Margin % | - | - | - | -1080.87% | -1423.1% | -2930.93% | -1618.56% | -1528% | -12584.26% | -2421.17% | -121.88% | -130.35% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -53.84M | -69.9M | -57.46M | -43.4M | -41.64M | -80.25M | -47.1M | -36.12M | -129.49M | -92.63M | -4.34M | -5.56M |
| Net Margin % | - | - | - | -1080.87% | -1423.1% | -2930.93% | -1618.56% | -1528% | -12584.26% | -2421.17% | -121.88% | -130.35% |
| Net Income Growth % | -29.3% | 12.9% | -21.99% | -20.14% | 67.84% | 13.37% | -984% | -550.03% | -2932.6% | -1089.75% | 49.08% | 37.73% |
| Net Income (Continuing) | -53.84M | -69.9M | -57.46M | -43.4M | -41.64M | -80.25M | -47.1M | -36.12M | -129.49M | -92.63M | -4.34M | -5.56M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.48 | -0.76 | -0.65 | -0.50 | -0.52 | -1.28 | -0.78 | -0.60 | -12.56 | -4.22 | -0.36 | -0.46 |
| EPS Growth % | 7.69% | 40.63% | 16.67% | 16.67% | 95.86% | 69.67% | -116.67% | -30.43% | -3706.06% | -511.59% | 48.57% | 37.84% |
| EPS (Basic) | -0.48 | -0.76 | -0.65 | -0.50 | -0.52 | -1.28 | -0.78 | -0.60 | -12.56 | -4.22 | -0.36 | -0.46 |
| Diluted Shares Outstanding | 113.14M | 87.35M | 87.96M | 87.01M | 79.41M | 62.7M | 60.21M | 59.94M | 10.31M | 21.95M | 12.2M | 12.2M |
| Basic Shares Outstanding | 113.14M | 87.35M | 87.96M | 87.01M | 79.41M | 62.7M | 60.21M | 59.94M | 10.31M | 21.95M | 12.2M | 12.2M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |